NewAmsterdam Pharma Company shares are trading lower after the company announced a secondary offering by selling shareholders of 10,579,210 shares for €0.12 per share.
Portfolio Pulse from Benzinga Newsdesk
NewAmsterdam Pharma Company announced a secondary offering by selling shareholders of 10,579,210 shares at €0.12 per share, causing the stock to trade lower.
June 07, 2023 | 3:41 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NewAmsterdam Pharma's stock price is trading lower due to the secondary offering of 10,579,210 shares at €0.12 per share.
The secondary offering of 10,579,210 shares at €0.12 per share has increased the supply of shares in the market, causing the stock price to trade lower. This is a direct impact on NewAmsterdam Pharma's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100